3 active not recruiting, 2 completed, 1 recruiting. 2 Phase 4, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Active not recruiting 1, Completed 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Cystic Fibrosis Gastrointestinal Disease: new trials by email Literature Review of Cystic Fibrosis Gastrointestinal Disease trials Research Report on Cystic Fibrosis Gastrointestinal Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gastrointestinal Response of Pediatric Cystic Fibrosis Patients on Mediterranean Diet Mediterranean diet - Cystic Fibrosis (CF), Cystic Fibrosis Gastrointestinal Disease | Not applicable | Recruiting | Dartmouth-Hitchcock Medical Center | 20 | 2026-09-01 | 2026-07-02 |
| Cardiac Structure and Function in Patients with Cystic Fibrosis Cystic Fibrosis, Cystic Fibrosis-related Diabetes | Active not recruiting | Herlev and Gentofte Hospital | 104 | 2023-01-01 | 2025-03-13 | |
| Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER) Elexacaftor/Tezacaftor/Ivacaftor - Cystic Fibrosis, Cystic Fibrosis Liver Disease | Phase 4 | Active not recruiting | Royal College of Surgeons, Ireland | 206 | 2020-09-03 | 2026-09-09 |
| Cystic Fibrosis and Gut Dysmotility: The Effect of Polyethylene Glycol (PEG) on Intestinal Transit Polyethylene Glycol 3350, SmartPill Motility System & PillCam Patency Capsule - Cystic Fibrosis Gastrointestinal Disease | Phase 4 | Completed | St. Louis University | 3 | 2019-12-12 | 2024-08-09 |
| Phase 2 Combination Study With Escalating Doses of MS1819-SD on Top of a Stable Dose of PPEs MS1819-SD - Cystic Fibrosis, Cystic Fibrosis Gastrointestinal Disease | Phase 2 | Completed | AzurRx SAS | 20 | 2019-06-27 | 2021-08-19 |
| Intestinal Inflammation in CF Patients Cystic Fibrosis in Children, Cystic Fibrosis Gastrointestinal Disease | Active not recruiting | The Hospital for Sick Children | 100 | 2018-09-11 | 2025-01-20 |
Cystic Fibrosis (6) · Cardiovascular Diseases (1) · Exocrine Pancreatic Insufficiency (1) · Heart Diseases (1) · Heart Failure (1) · Heart Failure, Diastolic (1) · Heart Failure, Systolic (1) · Medication Adherence (1) · Myocardial Infarction (1) · Stroke (1) · Ventricular Dysfunction, Left (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6) · Digestive System Diseases (6) · Genetic Diseases, Inborn (6) · Infant, Newborn, Diseases (6) · Lung Diseases (6) · Pancreatic Diseases (6) · Respiratory Tract Diseases (6) · Behavior (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Health Behavior (1) · Infarction (1) · Ischemia (1) · Myocardial Ischemia (1)
Diet, Mediterranean (1) · elexacaftor, ivacaftor, tezacaftor drug combination (1) · polyethylene glycol 3350 (1)
AzurRx SAS (1) · Dartmouth-Hitchcock Medical Center (1) · Herlev and Gentofte Hospital (1) · Royal College of Surgeons, Ireland (1) · St. Louis University (1) · The Hospital for Sick Children (1)
United States (2) · Canada (1) · Denmark (1) · Hungary (1) · Ireland (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Daniel Faurholt-Jepsen, MD PhD (1) · Dhiren Patel, MD (1) · Lisa S Duus, MD (1) · Maria Dons, MD (1) · Rebekka F Thudium, MD PhD (1) · Susanne D Poulsen, MD DMSc (1) · Tacjana Pressler, MD (1) · Tanja Gonska, MD (1) · Terese L Katzenstein, MD PhD DMSc (1)
PMID 15319624, PMID 16627012, PMID 22746323, PMID 24891257, PMID 27144634, PMID 27313953, PMID 28986022, PMID 37703083
P30DK117469 (1)